Charles River Laboratories International CRL
NYSE CRL
$282.06 +8.65 (+3.16%)
As of: Sep 17, 2026 · 3:59 PM EDT

Charles River Laboratories International (CRL) Current Deferred Tax Assets (2010 - 2011)

Charles River Laboratories International (CRL) posted Current Deferred Tax Assets of $28.5 million for Q3 2011, up 22.44% on a QoQ basis from $23.3 million in Q2 2011.

Analysis

Charles River Laboratories International (CRL) Current Deferred Tax Assets (2010 - 2011) Analysis & Trends

Charles River Laboratories International has reported Current Deferred Tax Assets for 2 years, with the latest figure at $28.5 million in Q3 2011.

  • On a quarterly basis, Current Deferred Tax Assets changed N/A year-over-year to $28.5 million in Q3 2011; TTM through Sep 2011 was $28.5 million, a N/A change from a year earlier, with the FY2010 full-year figure at $31.3 million, changed N/A from the prior year.
  • Current Deferred Tax Assets was $28.5 million for Q3 2011 at Charles River Laboratories International, up from $23.3 million in the prior quarter.
  • The five-year high for Current Deferred Tax Assets was $31.3 million in Q4 2010, with the low at $23.3 million in Q2 2011.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Iqvia Holdings 44.72 Bn 42.64 Bn 1.44 Bn
2 Medpace Holdings 17.37 Bn 16.87 Bn 201.64 Mn
3 Icon 13.65 Bn 12.72 Bn 479.29 Mn
4 Charles River Laboratories International 13.13 Bn 12.94 Bn 452.07 Mn
5 Fortrea Holdings 1.89 Bn 1.72 Bn 139.20 Mn
6 Evotec SE 574.75 Mn 148.87 Mn -
7 Ginkgo Bioworks Holdings 439.63 Mn 355.09 Mn 18.44 Mn
8 Champions Oncology 69.43 Mn 65.03 Mn 7.70 Mn
9 MindWalk Holdings 51.76 Mn 46.29 Mn 1.61 Mn
10 VivoSim Labs 1.37 Mn 1.37 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 24, 2011 28.52 Mn
Jun 25, 2011 23.29 Mn
Dec 25, 2010 31.25 Mn